St. Jude Medical Completes Acquisition of Thoratec
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
S&P Cuts St. Jude Medical (STJ) to 'A-' Following Closure of Thoratec Deal
October 8, 2015 5:08 PM EDTStandard & Poor's Ratings Services lowered its ratings on St. Jude Medical Inc. (NYSE: STJ), including the corporate credit rating and all issue-level ratings to 'A-' from 'A'. At the same time, we removed the ratings from CreditWatch, where we placed them with negative implications on July 22, 2015. The outlook is negative.
In conjunction with the... More
St. Jude Medical (STJ) Announces Completion of $3.3B Thoratec Acquisition
October 8, 2015 4:39 PM EDTSt. Jude Medical (NYSE: STJ) announced it has completed the previously announced acquisition of Thoratec Corporation, a worldwide leader in mechanical circulatory support (MCS) technology for the treatment of advanced heart failure (HF).
The acquisition will add the HeartMate II® VAD, the most widely used and extensively studied left ventricular assist device (VAD), as well as the next generation HeartMate 3, HeartMate PHP devices and other complementary products to St. Jude Medicals market-leading heart failure portfolio. With the addition of these product lines, St.... More
